Reaction
Growth Of Eyelashes reporting signals
As of the last recalculation, Growth Of Eyelashes appears in 786 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is BIMATOPROST (PRR 438.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bimatoprost | 297 | 438.0 | 442.6 |
| Travoprost | 41 | 132.3 | 133.0 |
| Erlotinib | 26 | 73.5 | 73.7 |
| Panitumumab | 41 | 73.1 | 73.3 |
| Latanoprost | 113 | 69.3 | 69.4 |
| Erlotinib Hydrochloride | 26 | 56.9 | 57.0 |
| Brinzolamide | 18 | 56.1 | 56.3 |
| Timolol Maleate | 19 | 52.0 | 52.1 |
| Dorzolamide Hydrochloride And Timolol Maleate | 13 | 44.3 | 44.3 |
| Brimonidine Tartrate | 24 | 36.8 | 36.8 |
| Gefitinib | 9 | 26.7 | 26.7 |
| Timolol | 11 | 24.4 | 24.5 |
| Carboxymethylcellulose Sodium | 6 | 17.0 | 17.0 |
| Cetuximab | 13 | 11.2 | 11.2 |
| Cenegermin-Bkbj | 5 | 11.0 | 11.0 |